Biofrontera Inc

Research Biofrontera Inc (BFRI) on Bullrun: market cap USD 13.06M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerBFRI
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryDrug Manufacturers-Specialty & Generic
• CurrencyUSD
• Market capUSD 13.06M
• Financial periodFY2025
• RevenueUSD 41.71M
• Revenue growth11.7%
• Net income-USD 10.54M
• Free cash flow-USD 13.36M

Valuation Snapshot

latest market cap is USD 13.06M.

About Biofrontera Inc

Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.

Frequently asked questions

What is Biofrontera Inc's market cap?

Biofrontera Inc's market capitalization is USD 13.06M.

What does Biofrontera Inc do?

Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.